ASCO Future Focus: NSCLC
<ѻý class="page-description">Future Focus from the American Society of Clinical Oncologyѻý>Patients by far prefer subcutaneous to intravenous medication delivery, says Jorge Nieva, MD
August 6, 2024
Streamlined approach broadens eligibility and reduces site burden
July 30, 2024
And minimal residual disease analysis may help determine length of therapy
July 23, 2024
<ѻý class="section_title"> Latest Oncology/Hematology Meeting Coverageѻý>
-
SABCS: San Antonio Breast Cancer Symposium
December 2024
-
ASH: Hematology: American Society of Hematology
December 2024
-
SNO: Society for NeuroOncology
November 2024
-
ASTRO: American Society for Radiation Oncology
September 2024